Ardsley Advisory Partners’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-15,000
| Closed | -$598K | – | 158 |
|
|
2017
Q4 | $598K | Buy |
+15,000
| New | +$598K | 0.07% | 79 |
|
|
2015
Q2 | – | Sell |
-981,300
| Closed | -$11.9M | – | 210 |
|
|
2015
Q1 | $11.9M | Sell |
981,300
-908,700
| -48% | -$11M | 1.65% | 18 |
|
|
2014
Q4 | $15.7M | Buy |
1,890,000
+75,000
| +4% | +$623K | 2.49% | 10 |
|
|
2014
Q3 | $15.8M | Buy |
1,815,000
+50,000
| +3% | +$434K | 2.08% | 9 |
|
|
2014
Q2 | $19.3M | Buy |
1,765,000
+175,000
| +11% | +$1.92M | 2.46% | 7 |
|
|
2014
Q1 | $14.2M | Buy |
1,590,000
+180,000
| +13% | +$1.61M | 2.13% | 11 |
|
|
2013
Q4 | $10.6M | Buy |
+1,410,000
| New | +$10.6M | 1.41% | 15 |
|